ZFP36 and ovarian cancer: In accordance with our findings, while changes in the expression level of Dicer was not frequently observed in ovarian cancer tissues [24], TTP loss is found in many types of cancers including ovarian cancer and this downregulation correlates with increased metastatic potential and poor prognosis [28, 32–34].